{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:11:15Z","timestamp":1792725075048,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.semarthrit.2014.12.001","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T14:35:33Z","timestamp":1418308533000},"page":"687-694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Scleroderma renal crisis"],"prefix":"10.1016","volume":"44","author":[{"given":"Nilanjana","family":"Bose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Chiesa-Vottero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2014.12.001_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/BOR.0b013e32834ff2e8","article-title":"Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers","volume":"24","author":"Barnes","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/ard.2009.127621","article-title":"Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma","volume":"70","author":"Domsic","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0889-857X(03)00016-4","article-title":"Scleroderma renal crisis","volume":"29","author":"Steen","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/qjmed\/hcp174","article-title":"Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study","volume":"103","author":"Nihtyanova","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib5","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972\u20132002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib6","first-page":"755","article-title":"Ein beitrag zur lehre vom haut-sklerem der erwachsenen","volume":"xiii","author":"Auspitz","year":"1863","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib7","series-title":"Rheumatology","first-page":"1373","article-title":"Clinical features of systemic sclerosis","author":"Hochberg","year":"2011"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF02595129","article-title":"Die diffuse sklerodermie und ihre gefassveranderung","volume":"302","author":"Masugi","year":"1938","journal-title":"Virchow S Arch Path Anat U Physiol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archinte.1939.00180200045005","article-title":"Dermatomyositis with scleroderma, calcinosis and renal endarteritis associated with focal cortical necrosis","volume":"63","author":"Talbott","year":"1939","journal-title":"Arch Int Med"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib10","first-page":"337","article-title":"The pathology of progressive systemic sclerosis (generalized scleroderma) with special reference to changes in viscera","volume":"4","author":"Goetz","year":"1945","journal-title":"Clin Proc"},{"issue":"6698","key":"10.1016\/j.semarthrit.2014.12.001_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0140-6736(52)91798-4","article-title":"The kidney of scleroderma","volume":"1","author":"MOORE","year":"1952","journal-title":"Lancet"},{"issue":"3 Suppl. 29","key":"10.1016\/j.semarthrit.2014.12.001_bib12","first-page":"S29","article-title":"Assessment of kidney involvement","volume":"21","author":"Steen","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib13","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.semarthrit.2013.09.008","article-title":"Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis: Results from the International Scleroderma Renal Crisis Survey","volume":"43","author":"Hudson","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","article-title":"Scleroderma renal crisis: patient characteristics and long-term outcomes","volume":"100","author":"Penn","year":"2007","journal-title":"QJM"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00005792-198311000-00001","article-title":"Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases","volume":"62","author":"Traub","year":"1983","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib17","first-page":"29","article-title":"Pathologic observations concerning the kidney in progressive systemic sclerosis","volume":"65","author":"Fisher","year":"1958","journal-title":"AMA Arch Pathol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197401000-00001","article-title":"The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation","volume":"53","author":"Cannon","year":"1974","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib19","doi-asserted-by":"crossref","first-page":"881","DOI":"10.7326\/0003-4819-89-6-881","article-title":"The kidney in progressive systemic sclerosis: a prospective study","volume":"89","author":"Kovalchik","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.1780370110","article-title":"Abnormalities of renal physiology in systemic sclerosis. A prospective study with 10-year followup","volume":"37","author":"Clements","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0749-0704(01)00004-5","article-title":"Thrombotic microangiopathies","volume":"18","author":"Halevy","year":"2002","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib22","doi-asserted-by":"crossref","first-page":"543704","DOI":"10.1155\/2010\/543704","article-title":"Scleroderma renal crisis: a pathology perspective","volume":"2010","author":"Batal","year":"2010","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib23","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.humpath.2008.08.001","article-title":"Renal biopsy findings predicting outcome in scleroderma renal crisis","volume":"40","author":"Batal","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib24","first-page":"649","article-title":"Kidney disease other than renal crisis in patients with diffuse scleroderma","volume":"32","author":"Steen","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/03009740802629424","article-title":"Renal function is mostly preserved in patients with systemic sclerosis","volume":"38","author":"Scheja","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib26","first-page":"1886","article-title":"Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma\u2014a different kind of renal crisis","volume":"33","author":"Kamen","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib27","first-page":"86","article-title":"Autoantibodies to myeloperoxidase in systemic sclerosis","volume":"24","author":"Locke","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib28","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0002-9343(84)90986-0","article-title":"Factors predicting development of renal involvement in progressive systemic sclerosis","volume":"76","author":"Steen","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/ard.2006.066985","article-title":"Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients","volume":"67","author":"Teixeira","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib30","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib31","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/BOR.0b013e3283108df7","article-title":"Diagnosis, management and prevention of scleroderma renal disease","volume":"20","author":"Penn","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib32","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00296-010-1697-6","article-title":"Corticosteroids and the risk of scleroderma renal crisis: a systematic review","volume":"32","author":"Trang","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib33","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/rheumatology\/ker271","article-title":"Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls","volume":"51","author":"Guillevin","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/rheumatology\/33.1.90","article-title":"Acute renal failure occurring in scleroderma treated with cyclosporin A: a report of three cases","volume":"33","author":"Denton","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib35","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/art.10589","article-title":"Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose d-penicillamine in early diffuse systemic sclerosis trial","volume":"46","author":"DeMarco","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib36","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/art.30111","article-title":"HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis","volume":"63","author":"Nguyen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib37","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s10067-012-1949-9","article-title":"Increased serum soluble CD147 levels in patients with systemic sclerosis: association with scleroderma renal crisis","volume":"31","author":"Yanaba","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib38","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.lfs.2003.07.034","article-title":"The endothelin receptor antagonist ameliorates the hypertensive phenotypes of transgenic hypertensive mice with renin-angiotensin genes and discloses roles of organ specific activation of endothelin system in transgenic mice","volume":"74","author":"Maki","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib39","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/art.22036","article-title":"Endothelin axis polymorphisms in patients with scleroderma","volume":"54","author":"Fonseca","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib40","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s100670050132","article-title":"Immunohistological study endothelin-1 and endothelin-A and B receptors in two patients with scleroderma renal crisis","volume":"18","author":"Kobayashi","year":"1999","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humpath.2010.05.018","article-title":"Endothelin-1 expression in scleroderma renal crisis","volume":"42","author":"Mouthon","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib42","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/qjmed\/hct111","article-title":"Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility","volume":"106","author":"Penn","year":"2013","journal-title":"QJM"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib43","first-page":"S573","article-title":"The N-terminal fragment of brain natriuretic peptide as an outcome predictor in scleroderma renal crisis","volume":"63","author":"Chighizola","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib44","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/rheumatology\/40.10.1157","article-title":"Anti-fibrillarin antibodies in systemic sclerosis","volume":"40","author":"Tormey","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1756-185X.2011.01688.x","article-title":"South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome","volume":"15","author":"Graf","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib47","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/rheumatology\/kep215","article-title":"A longitudinal study of anti-RNA polymerase III antibody levels in systemic sclerosis","volume":"48","author":"Nihtyanova","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib48","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.3899\/jrheum.080806","article-title":"Serologic profile and mortality rates of scleroderma renal crisis in Italy","volume":"36","author":"Codullo","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib49","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3899\/jrheum.091048","article-title":"Association of RNA polymerase III antibodies with scleroderma renal crisis","volume":"37","author":"Nguyen","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib50","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-133-8-200010170-00010","article-title":"Long-term outcomes of scleroderma renal crisis","volume":"133","author":"Steen","year":"2000","journal-title":"Ann Intern Med"},{"issue":"Suppl. 3","key":"10.1016\/j.semarthrit.2014.12.001_bib51","first-page":"iii32","article-title":"Renal complications and scleroderma renal crisis","volume":"48","author":"Denton","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib52","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s11255-013-0560-6","article-title":"Factors that can minimize bleeding complications after renal biopsy","volume":"46","author":"Zhu","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib53","first-page":"S377","article-title":"Scleroderma renal crisis and thrombotic thrombocytopenic purpura: are they related?","volume":"58","author":"Torok","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib54","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJM197906213002505","article-title":"Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade","volume":"300","author":"Lopez-Ovejero","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib55","doi-asserted-by":"crossref","first-page":"49P","DOI":"10.1177\/014107689608900114","article-title":"Favourable outcome of scleroderma renal crisis","volume":"89","author":"Collins","year":"1996","journal-title":"J R Soc Med"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib56","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1445-5994.2003.00358.x","article-title":"Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment","volume":"33","author":"Walker","year":"2003","journal-title":"Intern Med J"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib57","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/j.ajkd.2005.01.007","article-title":"Late recurrence of scleroderma renal crisis in a renal transplant recipient despite angiotensin II blockade","volume":"45","author":"Cheung","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib58","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.ajkd.2009.02.015","article-title":"Endothelin receptor antagonism and renin inhibition as treatment options for scleroderma kidney","volume":"54","author":"Dhaun","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.revmed.2010.02.004","article-title":"Systemic sclerosis and pregnancy","volume":"32","author":"Josselin-Mahr","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib60","first-page":"236","article-title":"Scleroderma at end stage renal disease in the United States: patient characteristics and survival","volume":"15","author":"Abbott","year":"2002","journal-title":"J Nephrol"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib61","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/art.1780160220","article-title":"Hemodialysis and kidney transplantation for renal failure from scleroderma","volume":"16","author":"Richardson","year":"1973","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib62","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00005792-199911000-00003","article-title":"Renal transplantation in scleroderma","volume":"78","author":"Chang","year":"1999","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib63","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/j.1600-6143.2004.00605.x","article-title":"Kidney transplantation for systemic sclerosis improves survival and may modulate disease activity","volume":"4","author":"Gibney","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib64","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/jama.1976.03270100032022","article-title":"Apparent recurrence of progressive systemic sclerosis in a renal allograft","volume":"236","author":"Woodhall","year":"1976","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib65","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1111\/j.1600-6143.2005.01035.x","article-title":"Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: case report and review of the literature","volume":"5","author":"Pham","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib66","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1002\/art.22965","article-title":"Prevention of vascular damage in scleroderma and autoimmune Raynaud\u2019s phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril","volume":"56","author":"Gliddon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.001_bib67","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-113-5-352","article-title":"Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors","volume":"113","author":"Steen","year":"1990","journal-title":"Ann Intern Med"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017214003217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017214003217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T06:55:06Z","timestamp":1566111306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017214003217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0049017214003217"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2014.12.001","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scleroderma renal crisis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2014.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}